Elizabeth A. Cairns

Access to cannabidiol without a prescription: A cross-country comparison and analysis

Iain S. McGregor, Elizabeth A. Cairns, Sarah V. Abelev et al. · International Journal of Drug Policy · 2020 · 108 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacology +14

The Cannabinoids Δ ⁸ THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation

Dinesh Thapa, Elizabeth A. Cairns, Anna-Maria Szczesniak et al. · Cannabis and Cannabinoid Research · 2018 · 99 citations · Full text

Medicine, Ophthalmology, Pharmacology +17

Medicinal Cannabis Prescribing in Australia: An Analysis of Trends Over the First Five Years

Sara L. Macphail, Miguel A. Bedoya‐Pérez, Rhys Cohen et al. · Frontiers in Pharmacology · 2022 · 67 citations · Full text

Pharmacy, Pharmaceutical Policy, Regulatory Pharmacy +13

Positive allosteric modulation of the type 1 cannabinoid receptor reduces the signs and symptoms of Huntington's disease in the R6/2 mouse model

Robert B. Laprairie, Amina M. Bagher, Jillian L. Rourke et al. · Neuropharmacology · 2019 · 53 citations · Full text

Life Sciences, Neuroscience, Pharmacology +16

The fatty acid amide hydrolase inhibitor, URB597, promotes retinal ganglion cell neuroprotection in a rat model of optic nerve axotomy

Joanna E. Slusar, Elizabeth A. Cairns, Anna-Maria Szczesniak et al. · Neuropharmacology · 2013 · 47 citations

Medicine, Neurobiology, Neuroscience +17